Jonathan Dimmock
Professor
Pharmacy
University of Saskatchewan
Canada
Biography
Dr. Dimmock is a medicinal chemist. He obtained his Ph. D. on the syntheses of candidate narcotic analgesics from the University of London, England and then worked as a research chemist in the industrial sector in the U.K. He joined the faculty of the College of Pharmacy (as it was then) in 1967 and rose to be a full professor in 1976. His teaching was principally devoted to a required course in medicinal chemistry and he initiated an elective on drug design. Much of this latter course was incorporated into a book entitled “An Introduction to Drug Design” which was published in 1997. In 1998 Dr. Dimmock received the University of Saskatchewan Students’ Union Teaching Excellence Award. In 2002 Dr. Dimmock retired in order to work full time in research principally in conjunction with Dr. Umashankar Das.
Research Interest
The research emphasis of Dr. Dimmock continues to be in the realm of cancer chemotherapy. In practice novel compounds are designed as anticancer drugs which are then synthesised and evaluated for their bioactivity. Specifically the principal group of molecules examined are conjugated unsaturated ketones which have an affinity for thiols and not amino and hydroxyl groups which are found in nucleic acids. An aim is to prepare compounds which demonstrate tumour-selective toxicity which are also effective against multidrug resistant tumours. Use is made of computer software packages which enables the shapes of active and inactive molecules to be compared as well as docking compounds to ascertain the extent of binding of molecules at a binding site of a specific enzyme. The modes of action of bioactive compounds are studied and in particular the effects of the novel compounds on mitochondrial function are noted. X-ray crystallography of representative molecules is undertaken to confirm the proposed structures and to reveal the shapes of molecules.
Publications
-
Panda AK, Das U, Roayapalley PK, Sakagami H, Kawase M, Balzarini J, De Clercq E, Dimmock JR. Niacin esters of chalcones with tumor-selective properties. Journal of enzyme inhibition and medicinal chemistry. 2016 Nov 1;31(6):1451-6.
-
Santiago-Vázquez Y, Das U, Varela-Ramirez A, T Baca S, Ayala-Marin Y, Lema C, Das S, Baryyan A, R Dimmock J, J Aguilera R. Tumor-selective cytotoxicity of a novel pentadiene analogue on human leukemia/lymphoma cells. Clinical cancer drugs. 2016 Oct 1;3(2):138-46.